(Q35022035)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475609%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

review article

1 reference

title

The GH-IGF-I axis and breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475609%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475609%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

author name string

Christiana Laban

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475609%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Paul J Jenkins

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475609%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475609%20AND%20SRC:MED&resulttype=core&format=json

Trends in Endocrinology and Metabolism

15 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475609%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475609%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

28-34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475609%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475609%20AND%20SRC:MED&resulttype=core&format=json

IGF-I Receptor-induced Cell-Cell Adhesion of MCF-7 Breast Cancer Cells Requires the Expression of Junction Protein ZO-1

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Activation of adenosine deaminase in MCF-7 cells through IGF-estrogen receptor alpha crosstalk

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Growth hormone treatment induces mammary gland hyperplasia in aging primates

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Polymorphic CA repeats in the IGF-I gene and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Insulin-like growth factor (IGF)-I rescues breast cancer cells from chemotherapy-induced cell death--proliferative and anti-apoptotic effects

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

High frequency of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice created from two different strains of mice

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II)

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Cellular expression of growth hormone and prolactin receptors in human breast disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Growth hormone receptor is expressed in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Expression of IGF-I and IGF-II mRNA in breast tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Insulin-like growth factor mediated stromal-epithelial interactions in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

IGF-I in human breast cancer: low differentiation stage is associated with decreased IGF-I content

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Type I insulin-like growth factor receptor function in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Insulin-like growth factor 1 receptors in human breast tumour: localisation and quantification by histo-autoradiographic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Insulin-like growth factor 1 receptors (IGF1-R) and IGF1 in human breast tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Insulin-like growth factors in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Insulin-Like growth factor I (IGF-I) and cyclic adenosine 3',5'-monophosphate regulate IGF-binding protein-3 gene expression by transcriptional and posttranscriptional mechanisms in mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Insulin-like growth factor binding protein-3 (IGFBP-3) potentiates paclitaxel-induced apoptosis in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Identification, Characterization, and Biological Activity of Specific Receptors for Natural (Ghrelin) and Synthetic Growth Hormone Secretagogues and Analogs in Human Breast Carcinomas and Cell Lines

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Somatostatin receptor subtypes sst1, sst2, sst3 and sst5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: comparison of mRNA analysis with receptor autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Analysis of somatostatin receptor subtype mRNA expression in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

IGF status is altered by tamoxifen in patients with breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Oestrogens, proteases and breast cancer. From cell lines to clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Role of AKT1 in 17beta-estradiol- and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Regulation of estrogen receptor-alpha gene expression by epidermal growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Effect of transforming growth factor-beta1, insulin-like growth factor-I and insulin-like growth factor-II on cell growth and oestrogen metabolism in human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Preclinical studies on the anticancer activity of the somatostatin analogue octreotide (SMS 201-995)

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

A randomized, multicenter prospective trial assessing long-acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Cancer and the potential place for growth hormone receptor antagonist therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin).

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021

Unraveling resistance to trastuzumab (Herceptin): insulin-like growth factor-I receptor, a new suspect.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900003-6

7 January 2021